Abstract:Background: Huang-Lian-Jie-Du-Tang (HLJDT), a famous traditional Chinese prescription with wide anti-inflammatory applications, is an aqueous extract of four herbal materials: Rhizoma coptidis, Radix scutellariae, Cortex phellodendri, and Fructus gardeniae. Its effects on the cyclooxygenase (COX)-2 and 5-lipoxygenase (5-LOX) pathways are thought to be responsible for its anti-inflammatory activity. However, our previous work found that the inhibitory effects of HLJDT act on the 5-LOX pathway but not on the COX pathway. The possibility that HLJDT inhibits COX-2- or 5-LOX-catalyzed eicosanoid generation by downregulating enzyme expression requires further investigation.Aim of the study: To observe the effects of HLJDT and its four major components (baicalin, baicalein, berberine and geniposide) on COX-2- or 5-LOX-catalyzed eicosanoid generation and to distinguish the effects of HLJDT on enzyme activity from those on enzyme expression.Methods: The topical anti-inflammatory activities and inhibition of eicosanoid formation of HLJDT and its components were observed in an arachidonic acid (AA)-induced mouse ear edema model. Macrophage-based systems were established to observe the effects of the drugs on enzyme activity and enzyme expression of COX-2 and 5-LOX. Further experiments were carried out to confirm these effects at the mRNA and protein levels.Results: Topical treatment of HLJDT significantly inhibited AA-induced mouse ear edema and reduced PGE(2) and LTB4 release in the edematous ears. Baicalein, geniposide, and berberine also ameliorated the symptoms and suppressed eicosanoid generation with varying efficacies. Cell-based assays showed that HLJDT and baicalein inhibited the PGE2 levels by decreasing COX-2 enzyme expression without affecting COX-2 enzyme activity in RAW 246.7 murine macrophages. The other experiments on rat peritoneal macrophages indicated that HLJDT and baicalein exerted significant inhibition on LTB4 production by decreasing 5-LOX enzyme activity. The real-time PCR and western blotting data demonstrated that HLJDT and baicalein reduced COX-2 expression at the mRNA and protein levels, whereas no inhibition on 5-LOX expression was observed.Conclusions: HLJDT can suppress eicosanoid generation via both the COX and LOX pathways, which definitely contributes to its topical anti-inflammatory activity. We have confirmed that its dual inhibition on the COX and LOX pathways mainly result from the downregulation of COX-2 expression and direct inhibition of 5-LOX activity, respectively. Baicalein worked as a potent active component in most of the tests. These findings about the different inhibitory effects of HLJDT on COX-2 and 5-LOX help to better understand the mechanism of HLJDT and promote safer applications of drug. (C) 2012 Elsevier Ireland Ltd. All rights reserved.

The anti-inflammatory effects of ZLJ-6, a novel dual cyclooxygenase/5-lipoxygenase inhibitor.

Antiplatelet and Antithrombotic Effects of ZLJ-6, an Inhibitor of Cyclooxygenase and 5-Lipoxygenase

ZLJ-6, a Novel COX/5-LOX Inhibitor, Attenuates TNF-α-induced Endothelial E-selectin, ICAM-1 and VCAM-1 Expression and Monocyte–endothelial Interactions Via a COX/5-LOX-independent Mechanism

ZLJ-6, a Novel COX/5-LOX Inhibitor, Ameliorates Atherosclerosis by Reducing Macrophage Infiltration in ApoE(-/-) Mice

Effect of COX/5-LOX dual inhibitor ZLJ-6 on the expression of LPS-induced inflammation factors in macrophage cells

Design of Balanced Cyclooxygenase Inhibitors Based on Natural Anti-inflammatory Ascidian Metabolites and Celecoxib

A Novel 1,5-Diarylpyrazole Derivative Exerts Its Anti-inflammatory Effect by Inhibition of Cyclooxygenase-2 Activity As a Prodrug

Discovery of 6‐Acylamino/Sulfonamido Benzoxazolone with IL‐6 Inhibitory Activity as Promising Therapeutic Agents for Ulcerative Colitis

Anti-inflammatory Effect and Mechanism of Compound ZLJ-601

Indole Derivatives As Potent Inhibitors of 5-Lipoxygenase: Design, Synthesis, Biological Evaluation, and Molecular Modeling.

CC 05, a Novel Anti-Inflammatory Compound, Exerts Its Effect by Inhibition of Cyclooxygenase-2 Activity.

Design, synthesis, and biological evaluation of dual-target COX-2/5-LOX inhibitors for the treatment of inflammation

Anti-Inflammation of Spirocyclopiperazinium Salt Compound LXM-10 Targeting Α7 Nachr and M4 Machr and Inhibiting JAK2/STAT3 Pathway in Rats

Anti-inflammatory Effect of the Spirocyclopiperazinium Compound LXM-10 in Mice and Rats

Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity

Discovery of Novel 2‐(piperidin‐4‐yl)‐1h‐benzo[d]imidazole Derivatives As Potential Anti‐Inflammatory Agents

The Different Inhibitory Effects of Huang-Lian-Jie-Du-Tang on Cyclooxygenase 2 and 5-Lipoxygenase

Design and synthesis of 1,3-benzothiazinone derivatives as potential anti-inflammatory agents

A rat air pouch model for evaluating the efficacy and selectivity of 5-lipoxygenase inhibitors

Design, synthesis and molecular docking of novel D-ring substituted steroidal 4,5-dihydropyrazole thiazole derivatives that act as iNOS/COX-2 inhibitors with potent anti-inflammatory activity against LPS-induced RAW264.7 macrophage cells

Discovery and Evaluation of Novel Synthetic 5-Alkyl-4-oxo-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoxaline-1-carbox-amide Derivatives As Anti-Inflammatory Agents